WellBiotec Co Ltd
KRX:010600

Watchlist Manager
WellBiotec Co Ltd Logo
WellBiotec Co Ltd
KRX:010600
Watchlist
Price: 545 KRW Market Closed
Market Cap: ₩1B

Balance Sheet

Balance Sheet Decomposition
WellBiotec Co Ltd

Balance Sheet
WellBiotec Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
361
1 609
512
678
1 219
2 110
1 706
7 251
2 100
3 505
4 185
3 897
2 824
2 279
4 281
3 078
8 509
18 495
10 659
1 748
3 909
10 414
10 084
7 327
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
1
1
0
0
Cash Equivalents
361
1 609
512
678
1 219
2 110
1 706
7 251
2 100
3 505
4 185
3 897
2 824
2 279
4 281
3 078
8 509
18 495
10 651
1 747
3 908
10 413
10 084
7 327
Short-Term Investments
6 332
5 198
4 564
5 582
6 338
13 803
14 533
9 831
60
580
623
626
78
0
0
0
0
12 548
12 361
6 553
4 014
3 212
5 199
1 000
Total Receivables
24 724
20 181
28 372
23 892
41 301
36 007
23 503
9 194
12 140
11 648
11 380
10 735
11 819
11 483
10 504
9 756
12 070
18 078
20 424
14 214
26 928
25 559
12 084
12 155
Accounts Receivables
24 121
18 600
26 802
22 585
39 606
34 312
20 790
7 824
10 247
9 480
11 040
10 561
11 124
10 910
10 165
9 371
9 862
16 937
19 697
13 900
21 840
21 003
10 936
10 849
Other Receivables
603
1 581
1 570
1 307
1 695
1 695
2 713
1 370
1 893
2 168
340
174
695
573
339
385
2 208
1 141
727
314
5 089
4 556
1 147
1 306
Inventory
17 892
36 296
50 188
58 782
59 990
51 315
20 214
28 590
21 399
21 657
30 048
28 309
29 095
28 169
23 959
26 001
23 751
16 821
17 283
5 403
1 789
1 063
1 663
0
Other Current Assets
741
2 467
1 925
2 128
4 242
5 076
1 100
1 604
4 419
1 258
2 588
1 491
1 949
1 439
2 104
2 010
1 582
5 683
11 625
2 011
87 745
6 684
9 716
3 488
Total Current Assets
50 051
65 752
85 561
91 061
113 090
108 309
61 057
56 472
40 117
38 649
48 824
45 057
45 766
43 370
40 847
40 845
45 912
71 625
72 351
29 929
124 386
46 932
38 747
23 970
PP&E Net
15 104
19 620
25 983
28 208
28 490
24 063
14 928
17 524
14 303
10 064
8 945
6 793
5 127
13 521
13 800
14 541
15 358
5 326
13 329
2 405
1 872
1 756
4 046
2 034
PP&E Gross
15 104
19 620
25 983
28 208
28 490
24 063
14 928
17 524
14 303
0
0
0
0
0
13 800
14 541
15 358
5 326
13 329
2 405
1 872
1 756
4 046
2 034
Accumulated Depreciation
12 397
16 917
19 010
19 098
19 780
15 457
6 207
10 990
12 296
0
0
0
0
0
20 559
19 073
18 251
17 372
20 773
2 128
1 328
1 482
1 614
1 326
Intangible Assets
1
314
1 684
1 668
3 276
5 671
5 447
6 965
2 105
55
42
38
34
31
35
381
2 331
1 493
5 234
1 364
1 390
1 225
234
225
Goodwill
0
0
0
0
0
0
2 484
1 863
0
10 470
9 337
5 837
5 837
0
0
0
1 210
6 045
12 714
5 443
3 604
2 942
0
0
Note Receivable
231
186
83
14
14
14
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
4 817
2 825
3 149
2 600
2 953
5 523
20 917
16 310
2 754
3 150
3 189
3 107
3 445
2 567
2 562
2 558
20 414
25 384
16 196
18 279
6 410
4 978
16 010
4 620
Other Long-Term Assets
1 327
3 165
4 332
5 612
3 326
2 299
743
675
1 037
1 138
818
982
1 019
1 765
1 844
1 539
1 781
1 284
0
13 500
1 722
1 452
1 204
1 100
Other Assets
0
0
0
0
0
0
2 484
1 863
0
10 470
9 337
5 837
5 837
0
0
0
1 210
6 045
12 714
5 443
3 604
2 942
0
0
Total Assets
71 531
N/A
91 861
+28%
120 792
+31%
129 163
+7%
151 148
+17%
145 880
-3%
105 590
-28%
99 809
-5%
60 315
-40%
63 527
+5%
71 155
+12%
61 814
-13%
61 228
-1%
61 253
+0%
59 088
-4%
59 865
+1%
87 006
+45%
111 158
+28%
119 824
+8%
70 921
-41%
139 383
+97%
59 285
-57%
60 241
+2%
31 948
-47%
Liabilities
Accounts Payable
1 206
16 445
30 042
28 630
44 349
31 814
10 052
11 227
7 710
6 027
8 183
7 468
6 588
4 903
3 710
3 985
5 739
4 996
6 088
5 009
7 265
9 135
7 074
2 259
Accrued Liabilities
533
806
1 321
1 026
955
1 621
1 170
1 085
606
989
641
555
415
452
412
400
566
455
750
415
442
344
1 901
1 807
Short-Term Debt
25 064
27 360
33 660
38 427
43 212
39 645
39 502
37 244
9 696
6 442
7 812
6 933
8 695
17 004
14 939
18 064
16 405
2 384
1 595
1 730
2 280
1 030
967
0
Current Portion of Long-Term Debt
3 891
187
74
8 719
2 642
5 548
10 332
373
1 852
5 914
1 581
981
0
0
0
650
34 087
21 832
20 698
30 586
21 184
4 572
5 600
810
Other Current Liabilities
5 452
9 426
10 942
13 899
13 349
11 515
2 783
834
761
5 197
6 714
3 744
3 905
2 299
2 280
2 275
1 949
4 532
3 714
3 999
69 489
7 558
5 029
5 851
Total Current Liabilities
36 147
54 224
76 040
90 700
104 506
90 144
63 839
50 762
20 625
24 570
24 931
19 680
19 602
24 659
21 340
25 374
58 746
34 198
32 845
41 740
100 661
22 640
20 570
10 726
Long-Term Debt
329
1 358
8 125
1 266
7 311
12 730
24
0
6 951
753
5 643
4 839
0
650
650
0
0
100
10 085
8 755
735
603
1 697
966
Deferred Income Tax
555
0
0
0
0
0
24
1 547
0
0
0
0
0
0
0
0
0
194
1
0
0
0
0
0
Minority Interest
0
4 019
3 533
2 732
3 746
5 885
6 117
1 633
0
442
236
243
276
197
202
195
1 388
1 733
667
504
485
534
786
1
Other Liabilities
813
1 410
1 732
1 367
1 418
1 624
246
232
300
800
905
1 254
937
824
525
632
1 410
264
1 257
936
958
740
754
71
Total Liabilities
37 844
N/A
61 011
+61%
89 428
+47%
96 064
+7%
116 980
+22%
110 382
-6%
70 250
-36%
54 175
-23%
27 876
-49%
26 565
-5%
31 715
+19%
26 016
-18%
20 816
-20%
26 329
+26%
22 718
-14%
26 202
+15%
61 544
+135%
36 488
-41%
43 521
+19%
51 935
+19%
102 840
+98%
24 517
-76%
22 235
-9%
11 765
-47%
Equity
Common Stock
8 723
8 977
8 977
8 977
8 977
9 108
10 379
36 779
39 411
57 237
5 724
6 140
7 093
7 625
7 625
7 625
7 625
18 480
21 505
22 655
29 339
33 216
45 462
45 462
Retained Earnings
17 960
15 315
15 646
19 160
19 861
19 473
16 026
11 639
20 133
30 352
28 749
31 843
29 342
35 998
35 316
37 897
46 639
61 839
78 038
145 428
181 327
102 063
167 094
185 362
Additional Paid In Capital
5 546
7 123
7 123
7 131
7 512
6 328
8 523
7 413
7 810
7 891
59 457
59 330
60 323
60 788
61 499
61 499
62 008
115 868
130 507
139 620
183 868
98 839
154 076
157 026
Unrealized Security Profit/Loss
2 003
48
180
0
0
1 891
1 864
8 338
1 864
1 864
1 864
1 864
1 850
1 919
1 864
1 928
2 025
1 666
1 893
1 952
1 864
1 864
2 064
2 225
Treasury Stock
798
580
580
580
580
0
386
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Other Equity
253
33
18
1 590
1 602
1 304
1 066
4 742
3 488
322
1 145
307
490
590
700
508
444
496
437
188
2 802
2 914
3 499
834
Total Equity
33 687
N/A
30 850
-8%
31 363
+2%
33 098
+6%
34 168
+3%
35 498
+4%
35 340
0%
45 634
+29%
32 439
-29%
36 962
+14%
39 440
+7%
35 797
-9%
40 413
+13%
34 924
-14%
36 370
+4%
33 663
-7%
25 462
-24%
74 669
+193%
76 303
+2%
18 986
-75%
36 544
+92%
34 769
-5%
38 006
+9%
20 183
-47%
Total Liabilities & Equity
71 531
N/A
91 861
+28%
120 792
+31%
129 163
+7%
151 148
+17%
145 880
-3%
105 590
-28%
99 809
-5%
60 315
-40%
63 527
+5%
71 155
+12%
61 814
-13%
61 228
-1%
61 253
+0%
59 088
-4%
59 865
+1%
87 006
+45%
111 158
+28%
119 824
+8%
70 921
-41%
139 383
+97%
59 285
-57%
60 241
+2%
31 948
-47%
Shares Outstanding
Common Shares Outstanding
2
2
2
2
2
2
3
7
8
11
11
12
14
15
15
15
15
37
43
45
59
66
91
91
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett